Can olanzapine (atypical antipsychotic) and mirtazapine (tetracyclic antidepressant) be continued during Electroconvulsive Therapy (ECT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Continuing Olanzapine and Mirtazapine During Electroconvulsive Therapy (ECT)

Both olanzapine and mirtazapine can be safely continued during electroconvulsive therapy (ECT) without significant adverse effects on treatment efficacy or safety. 1, 2

Safety and Efficacy of Continuing These Medications

Olanzapine During ECT

  • Olanzapine can be safely continued during ECT and may even provide beneficial effects 2
  • Recent research shows that concomitant olanzapine administration during ECT does not reduce the effectiveness of ECT treatment 2
  • Olanzapine has been shown to have epileptogenic properties that may actually enhance seizure activity during ECT 3
  • Orally disintegrating olanzapine has been used prophylactically to prevent postictal agitation in patients undergoing ECT 4

Mirtazapine During ECT

  • Mirtazapine can be safely continued during ECT and may enhance therapeutic effectiveness 1
  • Studies have shown that mirtazapine does not negatively impact seizure duration during ECT 1
  • Mirtazapine has been associated with lower postictal suppression, which does not interfere with ECT efficacy 1

Monitoring Considerations

Seizure Parameters

  • Monitor seizure duration closely as mirtazapine generally does not affect seizure duration, while olanzapine may potentially increase it 1, 3
  • Pay attention to postictal suppression, which may be lower in patients taking mirtazapine 1
  • Document seizure characteristics across sessions to detect any unusual patterns that might require adjustment 2

Potential Side Effects

  • Watch for increased sedation or drowsiness, as both medications can cause these effects 5
  • Monitor for orthostatic hypotension, particularly with olanzapine 5
  • Be vigilant for any signs of delirium or confusion post-ECT, though these are not specifically increased with these medications 6

Clinical Advantages

  • Continuing these medications may provide better overall treatment outcomes compared to discontinuing them before ECT 1, 2
  • The combination of ECT with these medications may enhance antidepressant efficacy 1
  • Maintaining psychiatric medication during ECT helps prevent relapse after the ECT course is completed 2
  • Recent evidence (2024) confirms that concomitant psychotropic medication during ECT "does not bare the risk of prolonged seizure duration or reduce the effectiveness of ECT" 2

Medications That Should Be Discontinued Before ECT

Unlike olanzapine and mirtazapine, certain medications should be discontinued prior to ECT:

  • Lithium should be discontinued when clinically possible due to risk of acute brain syndrome 7
  • Trazodone should be discontinued due to risk of prolonged seizures 7
  • Carbamazepine should be discontinued as it may prevent seizure induction 7
  • Theophylline should be discontinued as it can prolong seizure duration 7
  • Benzodiazepines may need to be tapered or discontinued as they increase seizure threshold 7, 6

Post-ECT Considerations

  • After completing the ECT course, continue olanzapine and mirtazapine as part of the maintenance treatment strategy 5
  • Systematic assessment of treatment outcomes should include evaluation of cognition, mood, psychosis, and other psychiatric symptoms 5
  • Regular follow-up is essential to monitor for mood changes or signs of suicidal ideation for several weeks after ECT 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.